About FDA
Number of highest risk domestic inspections in the month resulting in a classification of No Action Indicated (NAI)
Dictionary: The number of high-risk product inspections where no objectionable conditions or practices were found during the inspection (or the significance of the documented objectionable conditions found does not justify further FDA action) are classified as No Action Indicated.
Fiscal Year - 2010
| Time | Target | Number Classified as NAI |
|---|---|---|
| Oct 2009 | N/A | 340 |
| Nov 2009 | N/A | 474 |
| Dec 2009 | N/A | 513 |
| Jan 2010 | N/A | 510 |
| Feb 2010 | N/A | 483 |
| Mar 2010 | N/A | 673 |
| Apr 2010 | N/A | 515 |
| May 2010 | N/A | 569 |
| Jun 2010 | N/A | 828 |
| Jul 2010 | N/A | 452 |
| Aug 2010 | N/A | 556 |
| Sep 2010 | N/A | 463 |
FY 2010 Overall: 6,376
Percent of highest risk domestic inspections in the month resulting in a classification of No Action Indicated
Fiscal Year - 2010
| Time | Target | Percent Classified as NAI |
|---|---|---|
| Oct 2009 | N/A | 50 |
| Nov 2009 | N/A | 53 |
| Dec 2009 | N/A | 56 |
| Jan 2010 | N/A | 57 |
| Feb 2010 | N/A | 55 |
| Mar 2010 | N/A | 57 |
| Apr 2010 | N/A | 55 |
| May 2010 | N/A | 59 |
| Jun 2010 | N/A | 61 |
| Jul 2010 | N/A | 53 |
| Aug 2010 | N/A | 59 |
| Sep 2010 | N/A | 52 |
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
